Stock SANA SANA BIOTECHNOLOGY, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. Sana Biotechnology, Inc.

Equities

SANA

US7995661045

Market Closed - Nasdaq
Other stock markets
 01:30:00 30/04/2024 am IST 		5-day change 1st Jan Change
9.08 USD +4.13% Intraday chart for Sana Biotechnology, Inc. +14.50% +122.55%
18/04 Sana Biotechnology, Inc. Announces Resignation of Douglas Williams as Executive Vice President and President, Research and Development CI
09/04 Certain Restricted Stock Units of Sana Biotechnology, Inc. are subject to a Lock-Up Agreement Ending on 9-APR-2024. CI

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
JMP Securities Adjusts Sana Biotechnology Price Target to $15 From $8, Maintains Market Outperform Rating
MT
HC Wainwright Upgrades Sana Biotechnology to Buy From Neutral, Price Target is $12
MT
JMP Securities Trims Price Target on Sana Biotechnology to $8 From $9, Maintains Market Outperform Rating
MT
JMP Securities Initiates Sana Biotechnology With Market Outperform Rating, Price Target is $9
MT
Citigroup Starts Sana Biotechnology at Buy With $8 Price Target
MT
TD Cowen Initiates Sana Biotechnology at Market Perform
MT
HC Wainwright Starts Sana Biotechnology at Neutral
MT
Analysis-Biotech IPOs to bloom with spotlight on startups with human trial data
RE
Morgan Stanley Adjusts Price Target on Sana Biotechnology to $13 From $15, Maintains Overweight Rating
MT
Morgan Stanley Lowers Sana Biotechnology's Price Target to $15 From $17, Maintains Overweight Rating
MT
Morgan Stanley Adjusts Sana Biotechnology's Price Target to $17 from $40, Keeps Overweight Rating
MT
SANA BIOTECHNOLOGY : JPMorgan Adjusts Price Target for Sana Biotechnology to $31 From $35, Maintains Neutral Rating
MT
SANA BIOTECHNOLOGY : Goldman Sachs Adjusts Price Target on Sana Biotechnology to $34 From $39, Maintains Neutral Rating
MT
SANA BIOTECHNOLOGY : JPMorgan Starts Sana Biotechnology at Neutral With $35 Price Target
MT
SANA BIOTECHNOLOGY : Morgan Stanley Starts Sana Biotechnology at Overweight With $40 Price Target
MT
SANA BIOTECHNOLOGY : Goldman Sachs Starts Sana Biotechnology at Neutral With $40 Price Target
MT
SANA BIOTECHNOLOGY : BofA Securities Starts Sana Biotechnology at Buy With $45 Price Target
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. SANA Stock
  4. News Sana Biotechnology, Inc.
  5. Analyst Reco.